Healthcare - Press Releases

A new international study presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) reveals that IVF cycles involving male partners over the age of 45 carry significantly increased miscarriage risks and lower live birth rates - even when young donor eggs are used.

BRSSEL, 30. Juni 2025 /PRNewswire/ -- Fettleibigkeit fhrt zu einem starken Anstieg von Verdauungsstrungen und Krebserkrankungen in ganz Europa, insbesondere bei Menschen unter 50 Jahren, wo Stigmatisierung und geringes Bewusstsein eine frhzeitige Diagnose verzgern. Als Reaktion darauf veranstaltete die United EuropeanGastroenterology (UEG) Connecting the Dots: Obesity, Digestive Diseases and Cancers am 5. Juni im Europischen Parlament. Die Veranstaltung brachte politische Entscheidungstrger, Kliniker, Patientenvertreter und fhrende Persnlichkeiten des ffentlichen Gesundheitswesens zusammen, um dringende, koordinierte Manahmen zu fordern.

41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) vorgestellt wurde, zeigt, dass IVF-Zyklen mit mnnlichen Partnern ber 45 Jahren ein deutlich erhhtes Risiko fr Fehlgeburten und niedrigere Lebendgeburtenraten aufweisen - selbst wenn junge Spendereier verwendet werden.

Une nouvelle tude internationale prsente aujourd'hui lors de la 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) rvle que les cycles de FIV impliquant des partenaires masculins gs de plus de 45 ans prsentent des risques de fausses couches nettement plus levs et des taux de naissances vivantes plus faibles, mme lorsque des ovules de jeunes donneuses sont utiliss.

SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, held its Oncology R&D Day, unveiling its forward-looking strategy centered on dual innovation in next-generation immuno-oncology (IO) and antibody-drug conjugate (ADC) technologies. This strategic focus aims to redefine the standards of cancer treatment and propel Innovent toward becoming a global, premier biopharmaceutical leader. The event drew over 500 participants, including leading oncology key opinion leaders (KOLs), principal investigators, analysts, and global investors, signaling strong engagement with Innovent's transformative vision for the future of oncology.

Market Growth Driven by Rising Respiratory and Sleep Disorders, Aging Population, Advanced Device Technologies, and Expanding Home Healthcare Adoption

NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS).

- -

- Budovanie spoluprce medzi nou a Eurpou na ceste k zelenej a nzkouhlkovej budcnosti

Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International win Asia's Best CEO from Corporate Governance Asia

Market Growth Driven by Outsourcing Preferences, Advanced Manufacturing Technologies, Regulatory Compliance Expertise, and Industry 4.0 Integration

AMSTERDAM, 30 juin 2025 /PRNewswire/ -- Coway, leader sud-coren des technologies du bien-tre, a lanc sur le march europen l'Airmega 50, le modle le plus compact de sa gamme de purificateurs d'air ce jour. Ce tout nouveau modle fournit une purification de l'air haut de gamme dans les espaces quotidiens en mettant l'accent sur la portabilit, la performance et la tranquillit d'esprit.

AMSTERDAM, 27. Juni 2025 /PRNewswire/ -- Coway, Sdkoreas fhrendes Wellness-Tech-Unternehmen, hat den Airmega 50, das bisher kompakteste Modell seiner Luftreiniger-Reihe, auf dem europischen Markt eingefhrt. Diese neueste Version bringt erstklassige Luftreinigung in alltgliche Rume mit dem Schwerpunkt auf Tragbarkeit, Leistung und Seelenfrieden.

AMSTERDAM, 30 juni 2025 /PRNewswire/ -- Coway, het toonaangevende Zuid-Koreaanse bedrijf op gebied van wellness-technologie, lanceert de Airmega 50, het meest compacte model in het assortiment luchtzuiveraars tot nu toe, op de Europese markt. Deze nieuwste versie brengt luchtzuivering van topniveau in alledaagse ruimtes met aandacht voor draagbaarheid, prestaties en gemoedsrust.

CAMBRIDGE, Mass., June 29, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced an expansion of its researchcollaboration with Pfizer to pioneer a next-generation molecular modeling platform for drug discovery. This initiative is focused on improving the accuracy of advanced physics-based methods with the speed, scalability, and expansive coverage of cutting-edge AI models to optimize the discovery and development of small molecule medicines. Building on the success of their existing strategic collaboration, Pfizer and XtalPi will now collaborate on the development of an enhanced platform to grasp Pfizer's rapidly expanding small molecule chemical space, with the goal of delivering accurate predictive tools with significantly improved throughput.

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily, driven by rising incidence and improved diagnosis, positioning YUTIQ for strong market adoption.

SAN DIEGO, May 6, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutical class action lawsuit charges West Pharmaceutical and certain of West Pharmaceutical's current and former top executives with violations of the Securities Exchange Act of 1934.

Rsum de l'actualit

LEXINGTON, Mass., May 6, 2025 /PRNewswire/ --Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved the grant of inducement stock options to its newly appointed Chief Medical Officer, Dr. Ahmed Hamdy to purchase 200,000 shares of Curis common stock, with a grant date of May 1, 2025 (the "Inducement Grant").

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery. Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the superpotent corticosteroid, clobetasol propionate, and is derived from Formosa Pharma's proprietary APNT nanoparticle formulation platform. The novel formulation enables a convenient and straightforward dosing regimen, while providing rapid and sustained relief of inflammation and pain, which in Phase 3 trials proved statistically and clinically superior to its matching placebo (p<0.001).

WASHINGTON, May 6, 2025 /PRNewswire/ -- The Independence Fund, a national non-profit organization dedicated to serving the needs of catastrophically wounded Veterans and their families, was honored to join six of our nation's Veterans at today's Senate Committee on Veterans' Affairs hearing, "Veterans at the Forefront: Secretary Collins on the Future at VA."

SAN DIEGO, May 6, 2025 /PRNewswire/ -- Adcentrx Therapeutics("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead program, ADRX-0706, for the treatment of patients with locally advanced or metastatic squamous cell cervical cancer.

CHICAGO, May 6, 2025 /PRNewswire/ -- Veltex Corporation (OTCQB: VLXC), a premier Health and Wellness Acquisition Firm, is pleased to announce key enhancements to its leadership structure as part of its continued growth strategy and mission to serve communities impacted by substance use disorder.

LOS ANGELES, May 6, 2025 /PRNewswire/ -- Dr. Austin Harris, Dr. Austin Harris, MD, founder of NeuroRelief Ketamine & Infusion Therapy, offers a $1,000 grant to support student athletes balancing academics and sports. This scholarship is open to undergraduates at accredited U.S. colleges who show dedication both on the field and in the classroom.

CHICO, Calif., May 6, 2025 /PRNewswire/ -- Dr. ZacharyLipman, a dedicated physician and advocate for well-being, is pleased to announce the establishment of the Dr. Zachary Lipman Scholarship for Student Athletes. This one-time award of $1,000 aims to provide financial assistance to undergraduate students who actively participate in athletics and demonstrate a clear intention to pursue a career within the sports field.